What is Biovigil?
Headquartered in Ann Arbor, Michigan, Biovigil operates at the intersection of medical technology and operational efficiency. The company provides a sophisticated hand hygiene compliance system that utilizes patented sensor technology to ensure staff adherence to safety standards. Beyond simple monitoring, the Biovigil Data Suite offers hospital administrators granular insights into clinical workflows, enabling the optimization of resource allocation and the reduction of preventable healthcare-associated infections. By fostering a culture of accountability through gentle, real-time reminders, the platform has demonstrated the ability to sustain compliance rates as high as 97 percent, a benchmark that significantly impacts both patient safety and institutional liability.
How much funding has Biovigil raised?
Biovigil has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Biovigil
PPP
Public-Private Partnership
What's next for Biovigil?
With the support of its latest capital backing, Biovigil is poised to scale its footprint within the competitive landscape of digital health. The strategic focus will likely shift toward deepening the integration of its Data Suite within existing electronic health record systems, thereby enhancing the interoperability of its hygiene analytics. As hospitals increasingly prioritize infection control as a core component of their quality-of-care metrics, Biovigil is well-positioned to capture additional market share. Future growth initiatives will likely involve expanding the reach of its reminder technology into broader clinical environments, ensuring that the firm remains at the forefront of the global movement toward digitized, high-compliance medical facilities.
See full Biovigil company page
